Inventor

DUKHAN DAVID

FR26 patents

⚠️ This page may combine multiple inventors who share the name “DUKHAN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUKHAN DAVID

IDENIX PHARMACEUTICALS LLC

4′-or nucleosides for the treatment of HCV

Nucleotides for the treatment of liver cancer

Nucleotides for the treatment of cancer

3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

Nucleotides for the treatment of cancer

D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease

1′,4′-thio nucleosides for the treatment of HCV

D-amino acid compounds for liver disease

IDENIX PHARMACEUTICALS INC

3′,5′-cyclic phosphoramidate prodrugs for HCV infection

5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

Thiophosphate nucleosides for the treatment of HCV

3′-deoxy nucleosides for the treatment of HCV

3′,5′-cyclic phosphate prodrugs for HCV infection

Purine nucleoside analogues for treating flaviviridae including hepatitis C

5,5-fused arylene or heteroarylene hepatitis C virus inhibitors

MERCK SHARP & DOHME

Antiviral aliphatic ester prodrugs of tenofovir

Antiviral prodrugs of tenofovir

Antiviral aryl-amide phosphodiamide compounds

SURLERAUX DOMINIQUE

Compounds and pharmaceutical compositions for the treatment of viral infections

Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections

STORER RICHARD

Purine nucleoside analogues for treating flaviviridae including hepatitis C

DOUSSON CYRIL

Phosphothiophene and phosphothiazole HCV polymerase inhibitors

BOGEN STEPHANE

Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases

MSD INT GMBH

Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases

CENTRE NAT RECH SCIENT

Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV

AI BIOPHARMA

Anti-viral and hepatic-targeted drugs